Genpact (G) Lifts Tech Led Guidance, Is The Stock Still Cheap?

Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.

Why Genpact stock is back in focus after its latest earnings

Genpact (G) has returned to the spotlight after reporting second quarter 2026 results on 6 August, with higher revenue, profit and earnings per share, alongside fresh guidance and an ongoing share buyback.

See our latest analysis for Genpact.

Despite the strong second quarter update and guidance, Genpact’s recent 1 day share price return declined 5.17% and the year to date share price return is down 25.31%. The 1 year total shareholder return is down 19.79%, signalling that recent momentum has softened after a 16.75% 30 day share price gain.

If Genpact’s repositioning toward higher value technology work has your attention, it can also be useful to widen your watchlist with other automation and AI focused companies through 71 profitable AI stocks that aren’t just burning cash

Genpact’s earnings and guidance have not stopped the stock from falling this year, even after the recent rebound. Has the pullback already priced in the restructuring risk, or has the 30-day jump used up most of the remaining upside potential?

Most Popular Narrative: 12.7% Undervalued

The most followed narrative currently values Genpact at $39.27 per share, compared with the latest close of $34.29, which puts a spotlight on the recent pullback.

Genpact’s strong pipeline, particularly in high-growth verticals like high tech, manufacturing, and financial services, combined with increasing large-deal activity and stable operating leverage, sets the stage for above-sector-average revenue and EPS growth, aided by operating margin expansion and continued return of capital to shareholders.

Read the complete narrative.

Curious what sits behind that valuation gap? The narrative leans on steady revenue gains, firmer margins, and a future earnings profile that assumes disciplined capital returns. The exact mix of growth and profitability expectations might surprise you.

Result: Fair Value of $39.27 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, the Genpact narrative still faces pressure if slower core BPO demand persists or if heavier AI investment fails to translate into the expected premium contracts.

Find out about the key risks to this Genpact narrative.

Next Steps

With mixed sentiment running through the Genpact story, it helps to move quickly and test the numbers yourself rather than rely on headlines. To see what the optimism is built on, start by reviewing the 4 key rewards

Looking for more investment ideas beyond Genpact?

If Genpact is on your radar, do not stop there. A broader watchlist can reveal opportunities you might otherwise miss, especially when you compare quality, value and resilience.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include G.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com